James R. Kasinger sold $626K of CRISPR Therapeutics AG (CRSP)

Executed Sep 22, disclosed Sep 24, 2 days later.

Value, as filed

$626K

10,400 sh × $60.24

Executed

Sep 22

the trade date, as filed

Disclosed

Sep 24

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

James R. Kasinger General Counsel and Secretary profile →

James R. Kasinger (General Counsel and Secretary) filed 6 Form 4 reports in the trailing twelve months (0 purchases, 6 sales), most often in CRISPR Therapeutics AG (CRSP). The largest single filing was $626K of CRSP (10,400 sh × $60.24, as filed), executed Sep 22.

The name

CRSP

CRISPR Therapeutics AG CRSP · Healthcare · 39 filings in 24 months ticker →

Healthcare · CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered R…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by James R. Kasinger in CRSP

CRSPSALE CRISPR Therapeutics AG $119K
1,990 sh × $60.04
Exec Oct 6
Filed Oct 8 · 5:35 PM ET CRSPSALE CRISPR Therapeutics AG $149K
3,182 sh × $46.78
Exec Mar 23
Filed Mar 24 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $166K
3,450 sh × $48.26
Exec Mar 16
Filed Mar 17 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $148K
2,800 sh × $52.80
Exec Mar 11
Filed Mar 12 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $111K
2,112 sh × $52.58
Exec Feb 19
Filed Feb 20 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $131K
3,185 sh × $41.23
Exec Mar 21 2025
Filed Mar 24 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $121K
2,850 sh × $42.42
Exec Mar 11 2025
Filed Mar 12 2025 · 5:30 PM ET CRSPSALE CRISPR Therapeutics AG $619K
11,542 sh across 2 lots
Exec Feb 18 2025
Filed Feb 19 2025 · 5:30 PM ET